All forms of hormonal contraception carry breast cancer risk, study finds
Research shows small increase in risk until about five years after contraception is stopped, despite hopes that newer types might prove saferAll forms of the pill and other hormonal contraception carry a small risk of breast cancer, which lasts for about five years after women stop taking it, according to new research.The increased risk has been known for some time, but there were hopes that newer forms of hormonal contraception – such as those which release progesterone only – would be safer. However,the new study in the New England Journal of Medicine confirms the 20% added risk that women run – although that is still very small for those not at high risk already.Continue reading...
(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.
AbstractEnvironmentally benign-synthesized gold nanoparticles (Au-NPs) have received substantial attention owing to their biomedical applications, particularly in cancer therapy. In the current study,Backhousia citriodora (B. citriodora) leaf extract was applied as a reducing agent for one-pot synthesis of controlled size Au-NPs. The effect of various parameters such as reaction time, pH, andB. citriodora leaf boiling time on the synthesis of Au-NPs was studied. The characterization of the Au-NPs synthesized at 15.0-min incubation time showed colour change because of the surface plasma resonance band around 530.0 nm....
A second PARP inhibitor shows promise in germline mutation metastatic breast cancer and is generally well tolerated compared with standard chemotherapy.Medscape Medical News
Soy milk, tofu and edamame can help symptoms such as hot flashes and night sweats, found Georgetown Lombardi Comprehensive Cancer Center in Washington.
Women who forgo mammography screening may comply less to breast cancer treatment and may have worse outcomes, suggest two European studies, which also found that rates of screening may be falling.Medscape Medical News
Conditions: Metastatic Breast Cancer; HER2 Positive Breast Carcinoma Interventions: Drug: Niraparib; Drug: Trastuzumab Sponsors: University of Alabama at Birmingham; Translational Breast Cancer Research Consortium; Tesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation of Alabama Not yet recruiting
Condition: Breast Cancer Interventions: Drug: Trastuzumab; Drug: Docetaxel Sponsor: Ruijin Hospital Not yet recruiting
A small increased risk of breast cancer among women using hormonal contraceptives may be more than offset by the pills ’ protective effects.
Rates of bilateral mastectomy for breast cancer are increasing regardless of the success of chemotherapy, particularly in younger and white women and in those with private/managed health insurance.Medscape Medical News
Women who lose just 5% of their body weight after the menopause may experience a significant reduction in their risk of developing breast cancer vs women with stable weight, say US researchers.Medscape Medical News